Navamedic ASA: Invitation to 2024 1st quarter presentation

Publisert: 23.04.2024

Navamedic welcomes new shareholders

Publisert: 13.03.2024

Navamedic Q4 and full year 2023: A year marked by new records and transformative growth initiatives

Publisert: 15.02.2024

Navamedic ASA: Invitation to 2023 4th quarter presentation

Publisert: 13.02.2024

Navamedic ASA launches Eroxon®

Publisert: 12.02.2024

Navamedic ASA: Renewed contract signed with Vitaflo International Limited

Publisert: 21.12.2023